Milan, Italy

Carmelo A Gandolfi

This inventor holds 33 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Biochemia Robin S.p.a., Boehringer Mannheim Italia, Dompé Farmaceutici S.p.a.. Active years: 1987-2016.


% Patents Active = 90.9

 


Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • L'Aquila, IT (2005 - 2012)
  • Milan, IT (1987 - 2016)

Company Filing History:


Years Active: 1987-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antitumoral Compounds
Anti-Inflammatory Agents
Asthma Therapies
Dihydropyridines
Sulfonamides
Thiazolidines
Amino-Anthracenediones
Carboxylic Acids
Pharmaceutical Formulations
Chemotaxis Inhibition
Platinum Complexes
Coumarins
33 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Chemistry: The Contributions of Carmelo A Gandolfi

Introduction

Carmelo A Gandolfi, based in Milan, Italy, is a prominent inventor in the field of pharmaceutical chemistry. With a remarkable portfolio of 33 patents, his work primarily focuses on the development of compounds with therapeutic applications, particularly in the treatment of inflammatory conditions.

Latest Patents

Among his latest innovations, Gandolfi has developed omega-aminoalkylamides of R-2-aryl-propionic acids, which serve as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells. These (R)-2-arylpropionamide compounds have demonstrated utility in preventing tissue damage associated with excessive recruitment of immune cells at inflammatory sites. His patented formulations offer promising treatments for various conditions, including psoriasis, ulcerative colitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis, and in the prevention of injury caused by ischemia and reperfusion.

Career Highlights

Throughout his career, Carmelo A Gandolfi has been associated with respected companies such as Boehringer Biochemia Robin S.p.a. and Boehringer Mannheim Italia S.p.a. His contributions to the pharmaceutical industry have been significant, particularly in understanding and modulating immune cell responses through novel chemical derivatives.

Collaborations

In his journey, Gandolfi has collaborated with notable colleagues, including Sergio Tognella and Odoardo Tofanetti. These partnerships have likely enhanced the breadth and impact of his research, fostering an environment of innovation within the pharmaceutical sciences.

Conclusion

Carmelo A Gandolfi's work exemplifies the intersection of innovation and therapeutic applications, making strides in addressing complex medical conditions. His patents not only showcase creative problem-solving in pharmaceutical chemistry but also emphasize the importance of collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…